Is Estrone Stored in Subcutaneous Fat?
Estrone is not "stored" in subcutaneous fat in the traditional sense; rather, it is actively produced there through peripheral conversion of androgens, with adipose tissue serving as the primary site of estrone synthesis in postmenopausal women and a significant contributor in premenopausal women.
Estrone Production in Adipose Tissue
The relationship between estrone and adipose tissue is one of active biosynthesis rather than passive storage. According to authoritative guidelines, estrone is minimally produced by ovarian secretion; instead, most estrone is produced by peripheral conversion from adrenal and ovarian androstenedione, mainly in adipose tissue 1.
Key Mechanisms:
- Aromatase activity: Adipose tissue expresses high levels of aromatase (CYP19A1), which converts androgens (androstenedione and testosterone) into estrogens 2, 3
- Continuous production: This is an ongoing enzymatic process, not a storage depot mechanism
- Depot differences: Both subcutaneous and visceral adipose tissue produce estrone, though concentrations differ between depots 3
Adipose Tissue Estrogen Concentrations
Recent research demonstrates that estrone is the predominant estrogen in adipose tissue, with concentrations substantially higher than circulating serum levels:
In Postmenopausal Women:
- Estrone concentrations in visceral adipose tissue are higher than subcutaneous (median 928 vs 706 pmol/kg) 3
- Adipose tissue estrone levels exceed serum concentrations by 5-10 times 2
- Visceral adipose tissue estrone correlates positively with body mass index 3
In Premenopausal Women:
- Estrone dominates in adipose tissue despite estradiol being the predominant circulating estrogen 2
- Visceral adipose tissue contains higher estrone than subcutaneous (median 2657 vs 1459 pmol/kg) 2
- Local estrone concentration in visceral adipose tissue correlates positively with aromatase mRNA expression 2
Clinical Significance
Postmenopausal Context:
After menopause, adipose tissue becomes the predominant source of estrogen production 4, 5. The increased risk of endometrial cancer in postmenopausal women with obesity has been attributed to higher circulating concentrations of bioavailable estrogens created from the conversion of androstenedione to estrone in adipose tissue 4.
Obesity and Estrogen Exposure:
- Greater adipose tissue mass = increased aromatase activity = higher estrone production 3, 5
- This relationship explains why obesity increases systemic estrogen exposure in postmenopausal women
- Waist circumference correlates positively with estrogen production capacity 2, 3
Important Caveats
Estrone vs. Estradiol: While estrone is produced in adipose tissue, subcutaneous fat demonstrates greater capacity to convert estrone to the more potent estradiol through 17β-hydroxysteroid dehydrogenase activity 3. This depot-specific difference has metabolic implications.
Not True "Storage": Unlike fat-soluble vitamins or lipids that accumulate passively, estrone in adipose tissue reflects active enzymatic synthesis. The tissue doesn't "store" estrone—it manufactures it continuously from circulating androgen precursors.
Depot Heterogeneity: Visceral and subcutaneous adipose depots differ in their estrogen metabolism profiles, with visceral fat generally showing higher estrone concentrations but subcutaneous fat demonstrating more efficient conversion to estradiol 3, 6.